You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.
As cannabis consumers and the industry prepare to celebrate the most challenging 4/20 imaginable tomorrow, it’s easy to get caught up in the negativity of the current moment. Beyond the extensive loss of lives, the threat to the welfare of all of us and the unimaginable rapid loss of so many jobs, our industry in particular has been waylaid by the health crisis.
We have written extensively over the past month of the intensification of the capital crunch, and this will continue to weigh upon the industry for quite some time. It has also become clear that legal cannabis consumption will be challenged by logistical barriers as well as legal ones, like Massachusetts shutting down the adult-use market.
Many of the positive drivers we had expected to emerge in the back half of the year will now be deferred. The Canadian cannabis market is in desperate need of a quick roll out of the newly legal products like vape pens and edibles as well as the opening of stores in Ontario, but both of these will be delayed. In the United States, the potential for several states to legalize through the legislative process has slipped away, for now.
Despite these setbacks, we are more optimistic than ever that legalization efforts will be successful when the crisis passes, as state governments will be looking to plug massive budget deficits and add jobs.
Another silver lining is that the pandemic has moved several states to liberalize how patients and consumers access their cannabis, permitting curbside pickup and delivery when these were previously not allowed. We think that these are likely to become permanent fixtures, a move that could help the legal cannabis industry gain an edge over the illicit market, which certainly has enjoyed the convenience advantage.
Finally, while it is certainly tragic for the many companies that won’t make it, we think that some of the largest cannabis operators will enjoy greater market share when we emerge from this downturn.
Leading cannabis ancillary operator KushCo Holdings announced a new strategic plan of getting to positive Adjusted EBITDA when they released their FY20-Q2 results on April 10th. According to the company, and following comprehensive restructuring activities, it will benefit from significantly lower revenue levels needed to achieve profitability. Since 2010, KushCo has sold more than 1 billion units across North America, South America, and Europe to legally operated medical and adult-use dispensaries, growers, brands, processors, and producers. Today, 80% of business is now driven by a more stable, predictable, creditworthy and financially stronger customer group.
Get up to speed by visiting the KushCo Holdings Investor Dashboard that we maintain on their behalf as a client of New Cannabis Ventures. Click the blue Follow Company button in order to stay up to date with their progress.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Aphria Ramps Up Revenue in Fiscal Q3 to $144 Million
- Aurora Cannabis Seeks New ATM and to Consolidate Shares as Revenue Advances While Spending is Cut
- Cannabis Retail Platform Greenbits Raises $23 Million
- Breaking: CannTrust to Delist From New York Stock Exchange on April 27th
- Canopy Growth Closes Cannabis Cultivation Facilities Across the World to Make Global Operations More Efficient
- Green Acre Capital Leads $25 Million Fire & Flower Convertible Note Private Placement Financings
- Exclusive: Michigan Pure Med Is Using Its Hybrid Greenhouse and Lean Manufacturing to Go Deep in Its Home State
- Organigram Fiscal Q2 Revenue Declines 8% from Q1 to $23.2 Million
- Exclusive: This Company Just Reclaimed the Title of Leading Revenue Generator for Publicly Traded Multi-state Cannabis Operators
- Valens Generates $32 Million Revenue in Fiscal Q1
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5M per quarter.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Alan & Joel